Topical Minoxidil-Loaded Nanotechnology Strategies for Alopecia
Open Access
Abstract
Androgenetic alopecia (AGA) is a multifactorial and age-related condition characterized by substantial hair loss affecting both men and women. Conventional treatments include the use of topical minoxidil (MNX) formulations to stimulate hair growth and restore hair condition. However, those treatments are associated with limited performance and a lack of tolerability and compliance due to the emergence of adverse effects. Considering that the development of nanotechnology-based formulations as hair loss therapeutic strategies has been clearly growing, topical MNX delivery by means of these innovative formulations is known to enhance MNX skin permeation and depot formation into hair follicles, allowing for MNX-controlled release, increased MNX skin bioavailability and enhanced therapeutic efficacy with minimal adverse effects. This review highlights the potential of nanotechnology-based MNX delivery formulations for improved hair loss therapeutics, including a thorough assessment of their in vitro and in vivo performances, as well as regulatory and nanosafety considerations.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (SFRH/BD/148771/2019, SFRH/BD/136892/2018)
This publication has 89 references indexed in Scilit:
- Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopeciaSaudi Pharmaceutical Journal, 2013
- Different biokinetics of nanomedicines linking to their toxicity; an overviewDARU Journal of Pharmaceutical Sciences, 2013
- Nanocarriers and nanoparticles for skin care and dermatological treatmentsIndian Dermatology Online Journal, 2013
- Current Opinion on NanotoxicologyDARU Journal of Pharmaceutical Sciences, 2012
- Nanocarriers for transdermal drug deliveryResearch and Reports in Transdermal Drug Delivery, 2012
- Nanomedicine(s) under the MicroscopeMolecular Pharmaceutics, 2011
- Rheological behaviour of chitin in NaOH/urea aqueous solutionCarbohydrate Polymers, 2011
- Transferosomes - A vesicular transdermal delivery system for enhanced drug permeationJournal of Advanced Pharmaceutical Technology & Research, 2011
- In vitro skin permeation of monoolein nanoparticles containing hydroxypropyl β-cyclodextrin/minoxidil complexInternational Journal of Pharmaceutics, 2010
- Transdermal delivery of mixnoxidil with block copolymer nanoparticlesJournal of Controlled Release, 2004